Recombinant, chimaeric live, attenuated vaccine (ChimeriVax&unknown;) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective i

Authors: Monath T.P.; Soike K.; Levenbook I.; Zhang Z.-X.; Arroyo J.; Delagrave S.; Myers G.; Barrett A.D.T.; Shope R.E.; Ratterree M.; Chambers T.J.; Guirakhoo F.

Source: Vaccine, Volume 17, Number 15, 9 April 1999 , pp. 1869-1882(14)

Publisher: Elsevier

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S0264-410X(98)00487-3

Affiliations: 1: OraVax Inc., 38 Sidney Street, Cambridge, MA 02139, USA

Publication date: 1999-04-09

• In this: publication
• By this: publisher
• In this Subject: Animal Culture ,  Microbiology ,  Allergy & Immunology ,  Public Health ,  Veterinary Medicine
• By this author: Monath T.P. ;  Soike K. ;  Levenbook I. ;  Zhang Z.-X. ;  Arroyo J. ;  Delagrave S. ;  Myers G. ;  Barrett A.D.T. ;  Shope R.E. ;  Ratterree M. ;  Chambers T.J. ;  Guirakhoo F.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers